- Home
- TFFP vs ADIL Comparison
TFFP vs ADIL Comparison
Compare TFFP & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFFP
- ADIL
- Stock Information
- Founded
- TFFP 2018
- ADIL 2010
- Country
- TFFP United States
- ADIL United States
- Employees
- TFFP N/A
- ADIL N/A
- Industry
- TFFP Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- TFFP Health Care
- ADIL Health Care
- Exchange
- TFFP Nasdaq
- ADIL Nasdaq
- Market Cap
- TFFP 6.9M
- ADIL 6.5M
- IPO Year
- TFFP 2019
- ADIL 2018
- Fundamental
- Price
- TFFP $0.07
- ADIL $1.13
- Analyst Decision
- TFFP Strong Buy
- ADIL Strong Buy
- Analyst Count
- TFFP 1
- ADIL 1
- Target Price
- TFFP $44.00
- ADIL $8.00
- AVG Volume (30 Days)
- TFFP 5.0M
- ADIL 206.3K
- Earning Date
- TFFP 11-20-2024
- ADIL 11-13-2024
- Dividend Yield
- TFFP N/A
- ADIL N/A
- EPS Growth
- TFFP N/A
- ADIL N/A
- EPS
- TFFP N/A
- ADIL N/A
- Revenue
- TFFP $1,161,210.00
- ADIL N/A
- Revenue This Year
- TFFP $60.25
- ADIL N/A
- Revenue Next Year
- TFFP N/A
- ADIL N/A
- P/E Ratio
- TFFP N/A
- ADIL N/A
- Revenue Growth
- TFFP 24.55
- ADIL N/A
- 52 Week Low
- TFFP $0.06
- ADIL $0.77
- 52 Week High
- TFFP $11.00
- ADIL $4.17
- Technical
- Relative Strength Index (RSI)
- TFFP 20.20
- ADIL 55.23
- Support Level
- TFFP $0.06
- ADIL $1.05
- Resistance Level
- TFFP $0.31
- ADIL $1.27
- Average True Range (ATR)
- TFFP 0.04
- ADIL 0.09
- MACD
- TFFP 0.03
- ADIL -0.00
- Stochastic Oscillator
- TFFP 1.12
- ADIL 46.88
About TFFP TFF Pharmaceuticals Inc.
TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of lung disorders.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.